Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis-Reference-Cited by-同舟云学术

Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

Published:2011-08 Issue:12 Volume:47 Page:1826-1836
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Clarke Stephen J.,Yip Sonia,Brown Chris,van Hazel Guy A.,Ransom David T.,Goldstein David,Jeffrey G. Mark,Tebbutt Niall C.,Buck Martin,Lowenthal Raymond M.,Boland Amy,Gebski Val,Zalcberg John,Simes R. John

Funder

Pfizer Australia Pty Ltd

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Chemotherapy for operable and advanced colorectal cancer;Aschele;Cancer Treat Rev,2009

2. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer;Cassidy;J Clin Oncol,2008

3. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

4. Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer;Sobrero;Oncology,2009

5. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;Karapetis;N Engl J Med,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irinotecan plus raltitrexed as second‑line chemotherapy for metastatic colorectal cancer: A retrospective study;Oncology Letters;2024-06-28

2. Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis;BMC Cancer;2024-02-09

3. The effective combination therapies with irinotecan for colorectal cancer;Frontiers in Pharmacology;2024-02-05

4. Impact of sociodemographic factors and screening, diagnosis, and treatment strategies on colorectal cancer mortality in Brazil: A 20-year ecological study;PLOS ONE;2022-09-15

5. Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer;Journal of Cancer Research and Clinical Oncology;2022-03-22